The 14th World Congress of the International Pancreas and Islet Transplant Association will convene in Monterey, Calif., sponsored by the Transplantation Society and experts from UC San Francisco.
September 23, 2013
December 07, 2012
WHAT: Former UCSF transplant patient Alfonso Garcia, 18, has been selected as a rider on the Donate Life “Journeys of the Heart” float at the Tournament of Roses Parade in Pasadena, Calif., on January 1, 2013. He will do so to honor his donor, George Becker, who died at age 22 in 2010. A likeness of Becker will be captured in a floragraph, which is a portrait made of flowers, on the same float in this annual, internationally televised event.
October 22, 2012
Most liver transplant candidates who died or were removed from the transplant list actually received one or more liver donation offers, according to a recent UCSF study.
October 01, 2012
A $750,000 gift from the John and Marcia Goldman Foundation is spurring a UCSF-led effort to create the first implantable artificial kidney for patients with kidney failure.
January 03, 2012
Children with a rare, life-threatening disease that is the most common cause of neonatal liver failure – biliary atresia – better tolerate liver transplants from their mothers than from their fathers, according to a UCSF-led study.
October 26, 2011
The California Institute for Quantitative Biosciences (QB3) has signed an agreement with the Johnson & Johnson Corporate Office of Science and Technology (COSAT) to fund University of California proof-of-concept research that brings innovative science to market.
February 28, 2011
UCSF has received $48 million from the estate of Nina Ireland, a long-time supporter of UCSF, to further the university’s leadership in studying and treating a host of complex pulmonary conditions.
January 18, 2011
UCSF researchers have tackled a decade-long scientific conundrum, and their discovery is expected to lead to significant advances in using stem cells to treat genetic diseases before birth.
December 16, 2010
UCSF researchers have shown for the first time that the human fetal immune system arises from an entirely different source than the adult immune system, and is more likely to tolerate than fight foreign substances in its environment.
September 24, 2010
Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.